Serum BAFF expression in patients with myasthenia gravis
- 1 August 2008
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 199 (1-2) , 151-154
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signalingCurrent Opinion in Immunology, 2007
- The expression of BAFF‐binding receptors is not altered in multiple sclerosis or myasthenia gravisScandinavian Journal of Immunology, 2007
- BAFF, APRIL and human B cell disordersSeminars in Immunology, 2006
- The thymus is a source of B-cell-survival factors–APRIL and BAFF–in myasthenia gravisJournal of Neuroimmunology, 2006
- Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosisJournal of Neuroimmunology, 2004
- The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndromeAnnals of the Rheumatic Diseases, 2003
- Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseasesArthritis & Rheumatism, 2001
- Cutting Edge: A Role for B Lymphocyte Stimulator in Systemic Lupus ErythematosusThe Journal of Immunology, 2001